Skip to main content
. 2011 Jan 27;38(1):55–64. doi: 10.1159/000323786

Table 3.

Global overview of European countries where THERAFLEX MB-Plasma is in routine use or registered.

Country Country approvals In routine use % of therapeutic plasma
Austria 2008 2008 5
Belarus 2009
Belgium 2004 2004 98
Croatia 2006
Czech Republic 2005
France 2005 2008 55
Germany 2007
Greece 2000 2000 10
Italy 2002 2002 18
Lithuania 2004
Poland 2006 2008 0.1
Russia 2006 2006 5
Spain 1999 1999 65
Switzerland 2007
Ukraine 2007
UK 2002 2002 4*
*

Only used for children up to the age of 16.